Nitroglycerin shortage has medical community worried

Nitroglycerin shortage has medical community worried

(HealthDay)—An ongoing shortage of the drug nitroglycerin is causing problems and concerns for doctors and hospitals in the United States. The drug is often the first therapy used by emergency room doctors when treating a heart attack patient.

"It's one of those drugs that in certain circumstances, there really is no substitute for," Frederick Blum, M.D., an emergency doctor who treats patients at Ruby Memorial Hospital in West Virginia, told The New York Times. He added that nitroglycerin supplies are so low that "if we had one or two patients that were really sick that needed extended drips, it could exhaust our supply pretty quickly."

Hospitals and doctors became concerned they might run out of the drug when Baxter International, the only U.S. manufacturer of injectable nitroglycerin, recently said it was slashing shipments of the drug, The Times reported.

This week, Baxter and the U.S. Food and Drug Administration said they were taking action to ease the shortage of nitroglycerin.

More information: Health Highlights: March 26, 2014

add to favorites email to friend print save as pdf

Related Stories

FDA takes action to ease neonatal drug shortage

May 29, 2013

(AP)—Federal health regulators will allow overseas imports of a critical intravenous drug formula used to nourish premature infants, amid a shortage that has impacted hospitals nationwide.

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.